Literature DB >> 30709739

An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes.

Adam S Dingens1, Dana Arenz2, Haidyn Weight2, Julie Overbaugh3, Jesse D Bloom4.   

Abstract

Anti-HIV broadly neutralizing antibodies (bnAbs) have revealed vaccine targets on the virus's envelope (Env) protein and are themselves promising immunotherapies. The efficacy of bnAb-based therapies and vaccines depends in part on how readily the virus can escape neutralization. Although structural studies can define contacts between bnAbs and Env, only functional studies can define mutations that confer escape. Here, we mapped how all possible single amino acid mutations in Env affect neutralization of HIV by nine bnAbs targeting five epitopes. For most bnAbs, mutations at only a small fraction of structurally defined contact sites mediated escape, and most escape occurred at sites near, but not in direct contact with, the antibody. The Env mutations selected by two pooled bnAbs were similar to those expected from the combination of the bnAbs's independent action. Overall, our mutation-level antigenic atlas provides a comprehensive dataset for understanding viral immune escape and refining therapies and vaccines.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BG505; antibody immunotherapy; deep mutational scanning; immune escape; mutational antigenic profiling; virus evolution

Mesh:

Substances:

Year:  2019        PMID: 30709739      PMCID: PMC6435357          DOI: 10.1016/j.immuni.2018.12.017

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  76 in total

1.  Structural evolution of glycan recognition by a family of potent HIV antibodies.

Authors:  Fernando Garces; Devin Sok; Leopold Kong; Ryan McBride; Helen J Kim; Karen F Saye-Francisco; Jean-Philippe Julien; Yuanzi Hua; Albert Cupo; John P Moore; James C Paulson; Andrew B Ward; Dennis R Burton; Ian A Wilson
Journal:  Cell       Date:  2014-09-25       Impact factor: 41.582

2.  Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites.

Authors:  Samantha Townsley; Yun Li; Yury Kozyrev; Brad Cleveland; Shiu-Lok Hu
Journal:  J Virol       Date:  2015-10-28       Impact factor: 5.103

3.  PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4.

Authors:  Emilia Falkowska; Alejandra Ramos; Yu Feng; Tongqing Zhou; Stephanie Moquin; Laura M Walker; Xueling Wu; Michael S Seaman; Terri Wrin; Peter D Kwong; Richard T Wyatt; John R Mascola; Pascal Poignard; Dennis R Burton
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

4.  Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies.

Authors:  Alexandra Trkola; Herbert Kuster; Peter Rusert; Beda Joos; Marek Fischer; Christine Leemann; Amapola Manrique; Michael Huber; Manuela Rehr; Annette Oxenius; Rainer Weber; Gabriela Stiegler; Brigitta Vcelar; Hermann Katinger; Leonardo Aceto; Huldrych F Günthard
Journal:  Nat Med       Date:  2005-05-08       Impact factor: 53.440

5.  Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody.

Authors:  Rui Kong; Kai Xu; Tongqing Zhou; Priyamvada Acharya; Thomas Lemmin; Kevin Liu; Gabriel Ozorowski; Cinque Soto; Justin D Taft; Robert T Bailer; Evan M Cale; Lei Chen; Chang W Choi; Gwo-Yu Chuang; Nicole A Doria-Rose; Aliaksandr Druz; Ivelin S Georgiev; Jason Gorman; Jinghe Huang; M Gordon Joyce; Mark K Louder; Xiaochu Ma; Krisha McKee; Sijy O'Dell; Marie Pancera; Yongping Yang; Scott C Blanchard; Walther Mothes; Dennis R Burton; Wayne C Koff; Mark Connors; Andrew B Ward; Peter D Kwong; John R Mascola
Journal:  Science       Date:  2016-05-13       Impact factor: 47.728

6.  Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodies.

Authors:  N K Back; L Smit; M Schutten; P L Nara; M Tersmette; J Goudsmit
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

7.  Epitope-Independent Purification of Native-Like Envelope Trimers from Diverse HIV-1 Isolates.

Authors:  Hans P Verkerke; James A Williams; Miklos Guttman; Cassandra A Simonich; Yu Liang; Modestas Filipavicius; Shiu-Lok Hu; Julie Overbaugh; Kelly K Lee
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

8.  Mapping mutational effects along the evolutionary landscape of HIV envelope.

Authors:  Hugh K Haddox; Adam S Dingens; Sarah K Hilton; Julie Overbaugh; Jesse D Bloom
Journal:  Elife       Date:  2018-03-28       Impact factor: 8.140

9.  Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41.

Authors:  Catherine A Blish; Minh-An Nguyen; Julie Overbaugh
Journal:  PLoS Med       Date:  2008-01-03       Impact factor: 11.069

10.  Broad and potent neutralization of HIV-1 by a gp41-specific human antibody.

Authors:  Jinghe Huang; Gilad Ofek; Leo Laub; Mark K Louder; Nicole A Doria-Rose; Nancy S Longo; Hiromi Imamichi; Robert T Bailer; Bimal Chakrabarti; Shailendra K Sharma; S Munir Alam; Tao Wang; Yongping Yang; Baoshan Zhang; Stephen A Migueles; Richard Wyatt; Barton F Haynes; Peter D Kwong; John R Mascola; Mark Connors
Journal:  Nature       Date:  2012-09-18       Impact factor: 49.962

View more
  29 in total

1.  A facile method of mapping HIV-1 neutralizing epitopes using chemically masked cysteines and deep sequencing.

Authors:  Rohini Datta; Rohan Roy Chowdhury; Kavyashree Manjunath; Luke Elizabeth Hanna; Raghavan Varadarajan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-09       Impact factor: 11.205

Review 2.  Targeting the N332-supersite of the HIV-1 envelope for vaccine design.

Authors:  Thandeka Moyo; Dale Kitchin; Penny L Moore
Journal:  Expert Opin Ther Targets       Date:  2020-04-27       Impact factor: 6.902

3.  Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization.

Authors:  Rui Kong; Hongying Duan; Zizhang Sheng; Kai Xu; Priyamvada Acharya; Xuejun Chen; Cheng Cheng; Adam S Dingens; Jason Gorman; Mallika Sastry; Chen-Hsiang Shen; Baoshan Zhang; Tongqing Zhou; Gwo-Yu Chuang; Cara W Chao; Ying Gu; Alexander J Jafari; Mark K Louder; Sijy O'Dell; Ariana P Rowshan; Elise G Viox; Yiran Wang; Chang W Choi; Martin M Corcoran; Angela R Corrigan; Venkata P Dandey; Edward T Eng; Hui Geng; Kathryn E Foulds; Yicheng Guo; Young D Kwon; Bob Lin; Kevin Liu; Rosemarie D Mason; Martha C Nason; Tiffany Y Ohr; Li Ou; Reda Rawi; Edward K Sarfo; Arne Schön; John P Todd; Shuishu Wang; Hui Wei; Winston Wu; James C Mullikin; Robert T Bailer; Nicole A Doria-Rose; Gunilla B Karlsson Hedestam; Diana G Scorpio; Julie Overbaugh; Jesse D Bloom; Bridget Carragher; Clinton S Potter; Lawrence Shapiro; Peter D Kwong; John R Mascola
Journal:  Cell       Date:  2019-07-25       Impact factor: 41.582

4.  Deep Mutational Scanning Comprehensively Maps How Zika Envelope Protein Mutations Affect Viral Growth and Antibody Escape.

Authors:  Marion Sourisseau; Daniel J P Lawrence; Megan C Schwarz; Carina H Storrs; Ethan C Veit; Jesse D Bloom; Matthew J Evans
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

5.  Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1.

Authors:  Colin LaMont; Jakub Otwinowski; Kanika Vanshylla; Henning Gruell; Florian Klein; Armita Nourmohammad
Journal:  Elife       Date:  2022-07-19       Impact factor: 8.713

6.  Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses.

Authors:  Joshua J Tu; Amit Kumar; Elena E Giorgi; Joshua Eudailey; Celia C LaBranche; David R Martinez; Genevieve G Fouda; Yvetane Moreau; Allison Thomas; David Montefiori; Feng Gao; Manish Sagar; Sallie R Permar
Journal:  J Virol       Date:  2022-05-10       Impact factor: 6.549

7.  Probing the Structure of the HIV-1 Envelope Trimer Using Aspartate Scanning Mutagenesis.

Authors:  Raksha Das; Rohini Datta; Raghavan Varadarajan
Journal:  J Virol       Date:  2020-10-14       Impact factor: 5.103

8.  SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.

Authors:  Tyler N Starr; Nadine Czudnochowski; Zhuoming Liu; Fabrizia Zatta; Young-Jun Park; Amin Addetia; Dora Pinto; Martina Beltramello; Patrick Hernandez; Allison J Greaney; Roberta Marzi; William G Glass; Ivy Zhang; Adam S Dingens; John E Bowen; M Alejandra Tortorici; Alexandra C Walls; Jason A Wojcechowskyj; Anna De Marco; Laura E Rosen; Jiayi Zhou; Martin Montiel-Ruiz; Hannah Kaiser; Josh R Dillen; Heather Tucker; Jessica Bassi; Chiara Silacci-Fregni; Michael P Housley; Julia di Iulio; Gloria Lombardo; Maria Agostini; Nicole Sprugasci; Katja Culap; Stefano Jaconi; Marcel Meury; Exequiel Dellota; Rana Abdelnabi; Shi-Yan Caroline Foo; Elisabetta Cameroni; Spencer Stumpf; Tristan I Croll; Jay C Nix; Colin Havenar-Daughton; Luca Piccoli; Fabio Benigni; Johan Neyts; Amalio Telenti; Florian A Lempp; Matteo S Pizzuto; John D Chodera; Christy M Hebner; Herbert W Virgin; Sean P J Whelan; David Veesler; Davide Corti; Jesse D Bloom; Gyorgy Snell
Journal:  Nature       Date:  2021-07-14       Impact factor: 69.504

9.  Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1.

Authors:  Lynn N Bertagnolli; Joseph Varriale; Sarah Sweet; Jacqueline Brockhurst; Francesco R Simonetti; Jennifer White; Subul Beg; Kenneth Lynn; Karam Mounzer; Ian Frank; Pablo Tebas; Katharine J Bar; Luis J Montaner; Robert F Siliciano; Janet D Siliciano
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-25       Impact factor: 12.779

Review 10.  Applications of Deep Mutational Scanning in Virology.

Authors:  Thomas D Burton; Nicholas S Eyre
Journal:  Viruses       Date:  2021-05-28       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.